Sotera Health (SHC) Cash & Equivalents (2020 - 2026)

Sotera Health's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $314.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 3.21% year-over-year to $314.1 million; the TTM figure through Mar 2026 stood at $314.1 million (up 3.21% YoY), while the FY2025 annual figure was $344.6 million, up 24.3% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $314.1 million, down from $344.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $647.9 million in Q1 2023, with the low at $121.4 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $296.4 million (2023), against an average of $291.7 million.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 433.55% in 2023, then plunged 59.7% in 2024.
• Sotera Health's Cash & Equivalents stood at $395.2 million in 2022, then declined by 25.0% to $296.4 million in 2023, then fell by 6.47% to $277.2 million in 2024, then advanced by 24.3% to $344.6 million in 2025, then fell by 8.84% to $314.1 million in 2026.
• Business Quant data shows SHC's Cash & Equivalents at $314.1 million in Q1 2026, $344.6 million in Q4 2025, and $299.2 million in Q3 2025.